Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP466235.RAdEDYB5EEHD1szh0J8Y6CYNSfitY7NVuRiLNhD8R7qiM130_assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466235.RAdEDYB5EEHD1szh0J8Y6CYNSfitY7NVuRiLNhD8R7qiM130_provenance.
• NP712441.RAc1d8crmQ4T3K4R7tzjt9ea_sVvHqGap4VZBGBygXF_A130_assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712441.RAc1d8crmQ4T3K4R7tzjt9ea_sVvHqGap4VZBGBygXF_A130_provenance.
• assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1032635.RAetcedbSv6EBY8NEFGpfd4J8JDeGdfE36c4dFRsl858I130_assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032635.RAetcedbSv6EBY8NEFGpfd4J8JDeGdfE36c4dFRsl858I130_provenance.
• NP1032637.RAWrATNqqCwRJqcbrIhcU2o53vDtbdPo0NhcjVwaT44vk130_assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032637.RAWrATNqqCwRJqcbrIhcU2o53vDtbdPo0NhcjVwaT44vk130_provenance.
• NP1032638.RAWeKEp7887zE-nwXRgncEcnmBKf9QT7_rXbUyCmpkDv0130_assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032638.RAWeKEp7887zE-nwXRgncEcnmBKf9QT7_rXbUyCmpkDv0130_provenance.
• NP712301.RAjBYG51Q3mdVHn9p71Kf6tpKy4Eu-k_TyKdshU7MSQcc130_assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712301.RAjBYG51Q3mdVHn9p71Kf6tpKy4Eu-k_TyKdshU7MSQcc130_provenance.
• NP712377.RAsbCZ20tzrKeIgxmBq1DQUhzS8gxk9LxcDhvziDel5tQ130_assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712377.RAsbCZ20tzrKeIgxmBq1DQUhzS8gxk9LxcDhvziDel5tQ130_provenance.
• NP1032633.RAjh79rCdfM9mMqYRkGk165gKdOJ1geHI5KPzW3c-xcMU130_assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032633.RAjh79rCdfM9mMqYRkGk165gKdOJ1geHI5KPzW3c-xcMU130_provenance.
• NP466193.RAyFm-5GHP3cBjpaWt2bjpDNqXWkF4mH4khGknhHXAieA130_assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466193.RAyFm-5GHP3cBjpaWt2bjpDNqXWkF4mH4khGknhHXAieA130_provenance.
• NP466216.RA579nWb-xLa8J0mcXnEMRBj8BjHGcFoVZ-9yqFrq4vM4130_assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466216.RA579nWb-xLa8J0mcXnEMRBj8BjHGcFoVZ-9yqFrq4vM4130_provenance.
• NP1032643.RAEliQq0w3o_TEzwQOxcmh9Lwi0CtXJF4SfA3nw4hn5xY130_assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032643.RAEliQq0w3o_TEzwQOxcmh9Lwi0CtXJF4SfA3nw4hn5xY130_provenance.
• NP1032634.RAxvxNNagCfNS92nnrboN0liCkxktyySn-TngJ6D8m9kE130_assertion description "[Expression of HSD17B2 was 3.0-fold increased, and expression of SRD5A2 was 3.7-fold decreased, in EC versus adjacent control endometrium.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032634.RAxvxNNagCfNS92nnrboN0liCkxktyySn-TngJ6D8m9kE130_provenance.